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Abstract
Given two sets of data which lead to a similar statistical conclusion,
the Simpson Paradox [10] describes the tactic of combining these two
sets and achieving the opposite conclusion. Depending upon the given
data, this may or may not succeed. Inverse Simpson is a method
of decomposing a given set of comparison data into two disjoint sets
and achieving the opposite conclusion for each one. This is always
possible; however, the statistical significance of the conclusions does
depend upon the details of the given data.
1 Introduction
Anyone contemplating a statistical analysis is warned, at an early stage
of the game, “but don’t combine the statistics of monkey wrenches and
watermelons”, or the equivalent. Failure to heed this instruction – at a more
sophisticated level, to be sure – gives rise frequently to Simpson’s Paradox
(here, in its 2-trial sequence version): if choice A is “statistically better”
than choice B in each of two sets of trials under differing circumstances,
then it may happen that merging the two sets of data produces the opposite
conclusion. Consider the following specially constructed example for the
sake of illustration:
In Fig. 1, we pictorially represent trial sequence #1 by a solid line, trial
sequence #2 by a dashed line; trial #1 tests drug A, N1 times, drug B,
1
Table 1: Simpson Paradox Prototype
Trial #1 Trial #2 Total
SA ≡ A successes 60 60 120
FA ≡ A failures 20 140 160
SB ≡ B successes 140 20 160
FB ≡ B failures 60 60 120
60/80>140/200 and 60/200>20/80
but 120/280<160/280
N2 times, while trial #2 reverses the number of tests. The successes S,
and failures F are shown for each drug in each trial sequence. If a < b,
so 1 − a > 1 − b, then clearly the S/N ratio of drug A is larger than that
of B in both trial sequences, so drug A certainly seems better. But in
the combined trials SA/NA = ((1 − a)N1 + bN2)/(N1 + N2) is lower than
SB/NB = ((1−b)N2+aN1)/(N1+N2) if (1−a)N1+bN2 < (1−b)N2+aN1,
or
N1 <
1− 2b
1− 2a N2, (1.1)
a quite feasible circumstance, so that drug A has now become inferior to B!
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Figure 1: Simpson Paradox Prototype
This phenomenon is well-known and well-documented [5] [6] [7] [8] [9] [10]
– but hope springs eternal. Only recently [1], a drug manufacturer, whose
current potential blockbuster drug (Xinlay) failed to better a placebo in two
clinical trials with uncorrelated protocols, proposed to a regulatory agency
to pool the two sequences. If accepted, their drug would then outperform
the placebo, allowing them to move forward. The regulatory agency panel
was not unaware of the forced paradox, and denied the reinterpretation of
the data.
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2 Inverse Simpson
The Simpson Paradox is data-driven. As in (1.1), it may, or may not, hold
in a given situation. However, what we may term inverse Simpson paradox
is a different story: can we take a long pair of data streams – say successes
and failures with drug A, and similarly with drug B – and decompose them
into two pairs of subsequences, each of which reverses the conclusion of the
original pair? This can be carried out in different ways and for different
purposes,
a) Most directly and legitimately, it may be realized that data from two
sources were combined for simplicity, and so there is a unique decom-
position called for, which may indeed reverse the conclusion. This
appears to be the case in the oft-quoted Berkeley sex discrimination
controversy [5].
b) Least directly and least legitimately – but perhaps an effective strategy
in litigation – one can ask for that decomposition that maximally
reverses the conclusion, and then use ingenuity to characterize the
subsets thus obtained.
c) Putting a different spin on b), one can ask for that decomposition
that maximally comes jointly to either conclusion, and use this as an
investigative tool to recognize a hidden characterization of significant
subsets of related entities.
At first blush, inverse Simpson, in contexts b) and c), is trivially accom-
plished. Fig. 2 illustrates the principle.
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Figure 2: Inverse Simpson Prototype
The dotted lines refer to the assertedly pooled data, clearly indicating
that A loses to B. The hypothetical trial 1 data is represented by solid lines,
and since A has only successes, it is surely superior. And the dashed lines
refer to trial 2, in which B has only failures, and so surely loses.
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But Fig. 2 is a suspiciously extreme version of a strategy that can be
made to look more reasonable. To put it in context, let us consider the
well-known Berkeley sex discrimination case [5], which we will paraphrase
for numerical simplicity. The original data is that in one division, SA = 41
out of NA = 100 male applicants were admitted, a success rate of PA = .41.
On the other hand, SB = 29 of NB = 100 female applicants were admitted,
a success rate of only PB = .29. Clearly, it would seem that the admission
process discriminated against females. This was not the case. In fact,
Table 2: Simplified Berkeley Admission Data
Dept. 1 Dept. 2
Male Applicants 30 70
Males Admitted 6 35
Female Applicants 70 30
Females Admitted 14 15
Total Male Admissions/Applicants 41/100=.41
Total Female Admissions/Applicants 29/100=.29
Table 2, Simplified Berkeley Admission Data, was arrived at by combining
that of two departments, say 1 and 2. Referring to Table 2, we see that the
success rates of males in the two departments were PA1 = .2, PA2 = .5, with
the corresponding female success rates of PB1 = .2, PB2 = .5. There was no
demonstrable discrimination in either department, but “mixing watermelons
and monkey wrenches” created very much of a statistical artifact.
Let us proceed to a general situation. We are given NA and PA =
SA/NA, NB , and PB = SB/NB for which, without loss of generality, PA >
PB . We then imagine compartmentalizing the A-pool asNA1 = αNA, NA2 =
(1 − α)NA, and the B-pool as NB1 = βNB , NB2 = (1 − β)NB ; the success
rates are to be given via SA1 = PA1NA1, SA2 = PA2NA2, SB1 = PB1NB1,
SB2 = PB2NB2. The question then is whether α and β can be chosen so
that
PA1 = λ = PB1
PA2 = µ = PB2,
(2.1)
indicating no advantage to A or B in either case. This is trivial. Since
SA1 = αλNA, SA2 = (1 − α)µNA, SB1 = βλNB , SB2 = (1 − β)µNB , we
must have
PA = αλ+ (1− α)µ
PB = βλ+ (1− β)µ
(2.2)
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Figure 3: Placement of Averaging Parameters λ and µ
Thus, PA and PB are both averages of λ and µ, which therefore must lie
outside the interval (PB , PA) as in Fig. 3. Explicitly, of course, we have
α =
µ− PA
µ− λ β =
µ− PB
µ− λ
1− α = PA − λ
µ− λ 1− β =
PB − λ
µ− λ
(2.3)
In situations not as clear cut as the Berkeley case, we would want to invent
a hypothetical decomposition in which e.g. λ is roughly in the middle of
the (0, PB) interval, µ roughly in the middle of (PA, 1), in order to allay
suspicion. In the Berkeley case, we see that λ = .2, µ = .5 do satisfy this
criterion.
With (2.3), we find that a suitable decomposition removes the apparent
bias against females: no assertion can then be made. But Fig. 2 illustrates
a proactive strategy, in which a suitable decomposition reverses the original
assertion and appears to establish the superiority of A. What is wrong
with the construction of Fig. 2, aside from its suspicious extreme nature?
Nothing, but the conclusion is questionable because we have not attended to
the statistical significance of the new assertions, a point that was emphasized
by the FDA panel cited above. Doing so forms the substance of our ensuing
discussion.
3 Statistical Significance
A prototypical situation calling for statistical assessment is this. A sequence
of N independent Bernoulli trials – successes or failures – is carried out on
the same object, resulting in S successes. Given ǫ, with what probability, or
confidence, can we claim that p, the intrinsic success probability parameter,
satisfies
|p− S/N | ≤ ǫ/N1/2? (3.1)
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The standard approach is to start with the elementary result that, regarding
S as a random variable and defining q ≡ 1− p,
Pr(|S −Np| ≤ N1/2ǫ|p)
=
[Np+N1/2ǫ]∑
j=[Np−N1/2ǫ]
(
N
j
)
pjqN−j,
(3.2)
where [ ] denotes integer part. The device then is to identify (3.2), which is
a probability on S-space, with a probability on p-space:
Pr(|p− S/N | ≤ ǫ/N1/2|S) = Pr(|S −Np| ≤ N1/2ǫ|p) (3.3)
signifying our confidence that (3.1) holds.
The sort of information that will interest us will, however, in the con-
text of this prototype, be more like: with what confidence, based upon the
observed value of S, can we claim that
p ≥ 1/2? (3.4)
Now, the above recipe is not readily applicable, since we are no longer ques-
tioning a relationship between p and S that makes possible the sub rosa
journey from S-space to p-space. But this is indeed the province of the
Bayes approach [4] which – ignoring the controversy that continues to swirl
around it – is what we will use. First of all, let up recall what (3.1) would
become in a Bayesian context: we imagine joint (p, S)-space and quote the
obvious
Pr(p = p′|S = S′) = Pr(S = S′|p = p′) f(p′)/Z
whereZ =
∫ ′
0
Pr(S = S′|p = p′′) f(p′′)dp′′, (3.5)
f here referring to probability density. If f(p′) is the prior density on p-
space, then
Pr(|p − S/N | ≤ ǫ/N1/2|S = S′)
=
∫ S′/N+ǫ/N1/2
S′/N−ǫ/N1/2
f(p′)p′S
′
q′N−S
′
dp′/Z
Z =
∫ ′
0
f(p′)p′S
′
q′N−S
′
dp′.
(3.6)
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But suppose we choose a uniform prior, f(p) = 1; then (3.6) becomes
Pr(|p− S/N | ≤ ǫ/N1/2)
=
∫ min(S′/N+ǫ/N1/2,N)
max(O,S′/N−ǫ/N1/2)
p′Sq′N−Sdp′/Z
Z =
∫ ′
0
p′Sq′N−Sdp′ = ((N + 1)
(
N
S
)
)−1.
(3.7)
Eqs. (3.2, 3.3) and (3.7) are certainly not identical, but if we go to the large
sample regime, i.e. the normal approximation to the binomial, then (3.2,
3.3) aver that
Pr(|p− S/N | ≤ ǫ/N1/2) =
∫ ǫ/√pq
−ǫ/√pq
e−
1
2
s′2ds′/
√
2π, (3.8)
which, it is easy to show is identical with the large N , fixed S/N , steepest
descent expansion [3] of (3.7) around p′ = S/N .
On the basis of the above equivalence, we now go immediately to the
question indicated by (3.4). Using Bayes with a uniform prior, precisely as
in (3.7), we have
Pr
(
p ≥ 1
2
)
=
∫ 1
1/2
p′Sq′N−Sdp′/
∫ 1
0
p′Sq′N−Sdp′
= 1−B1/2(S + 1, N + 1− S)/B(S + 1, N + 1− S),
(3.9)
where B is the Beta function, B1/2 the corresponding incomplete Beta func-
tion [2]. Eq. (3.9) can also be written in the neat form
Pr
(
p ≥ 1
2
)
= 1−
N−S∑
j=0
(
N+1
j
)
pN+1−jqj|p= 1
2
= 1−
N−S∑
j=0
(
N+1
j
)
/2N+1
(3.10)
The important point however is that this construction leads quite directly
to evaluation of quantities such as Pr(pA ≥ pB), that are appropriate to the
Simpson paradox.
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4 Level of Significance of the Inverse Paradox
The effect we are studying is not very subtle, and so it is sufficient to take
a large sample limit, which strategy we adopt. However, there are several
sample parameters, leading to the meaningful use of additional limiting op-
erations. Consider first the prototype, Eq. (3.10); here,
αN (S) =
N−S∑
j=0
(
N+1
j
)
/2N+1 (4.1)
expresses the level of significance of the assertion that p ≥ 12 , and it is not
until such an assessment is made that one can declare meaningful compar-
isons. Let us evaluate (4.1) in the large sample limit in a familiar fashion
that extends at once to the question of Pr(pA ≥ pB) relevant to the Simpson
paradox.
Although (4.1) is finite and explicit, its implementation for large N and
S – while trivial numerically – is a bit complex. For this purpose, the
expression (3.9) is more useful; it says that
αN (S) =
∫ 1/2
0
pS(1− p)N−Sdp/
∫ 1
0
pS(1− p)N−Sdp. (4.2)
By the large sample limit, we will mean that in which
s = N−1/2
(
S − 1
2
N
)
(4.3)
is fixed (to within N−1/2) as N →∞, and we then ask for
α(s) = lim
N→∞
αN (S). (4.4)
This is obtained quite directly by a steepest descent evaluation [3] of (4.2).
The relevant integrand is now
I(p) ≡ pS(1− p)N−S
= exp
[(
N
2
+N1/2s
)
ln p+
(
N
2
−N1/2s
)
ln (1− p)
]
,
(4.5)
with a maximum at
p0 =
1
2
+N−1/2s, (4.6)
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and a corresponding expansion starting as
I(p) = I(p0) exp−
[
N
2
(p − p0)2/
(
1
4
− s
2
N
)]
. (4.7)
Hence
α(s) = lim
N→∞
∫ 1/2
0
e−2N(p−p0)
2
dp/
∫ 1
0
e−2N(p−p0)
2
dp
= lim
N→∞
∫ −2s
−N1/2−2s
e−x
2/2dx/
∫ N1/2−2s
−N1/2−2s
e−x
2/2dx
=
∫ −2s
−∞
e−x
2/2dx/
∫ ∞
−∞
e−x
2/2dx,
(4.8)
immediately recognizable in a normal distribution context.
We can then proceed to the desired evaluation of
Pr(pA ≥ pB |SA, SB, NA, NB) =∫∫
1≥pA≥pB≥0
[f(pA, pB)
Pr(SA, SB , |pA, pB , NANB)]dpA dpB/∫∫
1≥pA≥0
1≥pB≥0
[f(pA, pB)
Pr(SA, SB |pA, pB , NA, NB)]dpA dpB .
(4.9)
This is carried out in Appendix A, where we choose Bayes with uniform
prior on pA, pB space and process (4.9) as we did (4.2). The result is that
for large NA, NB ,
P r(pA ≥ pB) = φ
(
SA
NA
− SB
NB
/(
SA(NA − SA)
NA3
+
SB(NB − SB)
NB3
)1/2)
whereφ(x) =
1√
2π
∫ x
−∞
e−
1
2
y2dy
(4.10)
Unsurprisingly, we can obtain (4.10) as well by a version of the proba-
bility space equivalence assertion employed in (3.3). It is only necessary to
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consider the random variable
ξ =
SA
NA
− SB
NB
(4.11)
where SA and SB are binomially distributed with success probabilities pA
and pB. Since we find at once that
E(e
γ
“
SA
NA
− SB
NB
”
)
= (pAe
γ/NA + qA)
NA(pBe
−γ/NB + qB)NB ,
(4.12)
it follows directly that
E(ξ|pA, pB) = pA − pB
Var(ξ|pA, pB) = pA
NA
qA +
pB
NB
qB
(4.13)
and then from the central limit theorem that in the limit NA, NB →∞,
Pr
(
SA
NA
− SB
NB
≥ pA − pB +∆|pA, pB
)
= φ(−∆/(pAqA/NA + pBqB/NB)1/2)
(4.14)
The same sleight of hand as in (3.3) then converts this to
Pr
(
pA − pB ≤ SA
NA
− SB
NB
−∆|SA, SB
)
= φ
(
−∆/
(
SA(NA − SA)
N3A
+
SB(NB − SB)
N3B
)1/2)
,
(4.15)
and so, setting ∆ = SANA −
SB
NB
, to (4.10), as was to be shown.
5 Realizations of the Inverse Paradox
Now let us make use of the result (4.10). If our initial data is characterized
by SA, SB , NA + NS = N , and PA = SA/NA, PB = SB/NB , then the
confidence level with which we can assert that pA ≥ pB is given by
φ(N1/2CAB)
CAB = (PA − PB)/σAB > 0
σ2AB =
PA(1− PA)
NA/N
+
PB(1− PB)
NB/N
.
(5.1)
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Our objective is to supply a decomposition into two hypothetical trials
(SA1, NA1,
SB1, NB1) and (SA2, NA2, SB2, NB2) such that
ifC ′i = (PBi − PAi)/σi, i = 1, 2
wherePAi = SAi/NAi, PBi = SBi/NBi
σ2i =
PAi(1− PAi)
NAi/N
+
PBi(1− PBi)
NBi/N
,
thenC ′i > 0 for i = 1, 2.
(5.2)
In fact, to be definite, we suppose that the two pairs of trials reverse the
initial assertion at a common level of confidence
(PB1 − PA1)/σ1 = C ′ = (PB2 − PA2)/σ2 (5.3)
with C ′ > 0. To start, we need to find the restrictions on C ′ under which
the required (PA1, PA2, PB1, PB2) satisfying (5.2) can be found.
The solution is direct but algebraically cumbersome, and is presented in
detail in Appendices B and C. The conclusion of the former is that if α ≥ β,
then
C ′ ≤ min
(
β¯P¯A − α¯P¯B
α¯σB
,
β¯P¯A − α¯P¯B
β¯σA
,
αPB − βPA
ασB
,
αPB − βPA
βσA
)
.
(5.4)
Since we require C ′ ≥ 0, this implies that
α/β ≥ PA/PB ≥ 1, β¯/α¯ ≥ P¯B/P¯A ≥ 1. (5.5)
In (5.4) and (5.5), we uniformly adopt the notation:
if 0 ≤ x ≤ 1, then x¯ ≡ 1− x. (5.6)
Eq. (5.4) is a bit involved and, even worse, contains the unknown pa-
rameters pAi, pBi implicitly. But it can be simplified by reducing its right
hand side and thereby strengthening the requirement on C ′ a bit. This is
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carried out in Appendix C, with the conclusion that, if α ≥ β, then
PA + PB ≥ 1 : C ′ ≤ 2(γγ¯)1/2((P¯B/P¯A)2 − 1)
(PA − PB)(PB/PA)/
[(
PA
PB
P¯B
P¯A
)2
− 1
]
PA + PB ≤ 1 : C ′ ≤ 2(γγ¯)1/2((PA/PB)2 − 1)
(PA − PB)(P¯A/P¯B)/
[(
PA
PB
P¯B
P¯A
)2
− 1
]
where γ = NA/N
(5.7)
are sufficient to carry out the apparent reversal of ranking of A and B.
Let us take a simple example that has been previously quoted [4] [8]. We
will paraphrase it and use rounded off data. Hospitals A and B specialize
in treating a certain deadly disease. NA = 1000 patients are treated at A
and NB = 1000 at B. Of these, SA = 900 recover, while SB = 800 recover,
so that PA = .9, PB = .8 and Hospital A is apparently the place to go.
In fact, one computes CAB = .05, so that this conclusion is supported at
the .05 × (2000)1/2 = 2.24 standard deviation level. Detailed investigation
shows that matters are not so simple. Some patients enter in otherwise good
shape, others in poor shape. Of the former, NA1 = 900 enter hospital A, and
870 recover; of the latter, NA2 = 100 enter and 30 recover, so PA1 = .967,
PA2 = .3.
Table 3: Simplified Hospital Recovery Data
Good Shape Poor Shape
Admissions to Hospital A 900 100
Recovered in Hospital A 870 30
Admissions to Hospital B 600 400
Recovered in Hospital B 590 210
Total Recovered/Admissions in A: 900/1000=.9
Total Recovered/Admissions in B: 800/1000=.8
On the other hand, NB1 = 600 enter Hospital B in good shape and
SB1 = 590 recover, whereas NB2 = 400, SB2 = 210. Thus, PB1 = .983,
PB2 = .55. We see that by not mixing the two classes of patients, Hospital
B is superior for each class – at levels C ′1 = .038 (1.7 standard deviations)
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and C ′2 = .176 (7.9 standard deviations). Simpson, or inverse Simpson,
depending upon one’s point of view, is certainly exemplified.
Of course, the criteria as to which patients entered in good shape, which
in poor shape, are a bit fuzzy. Given the aggregate data, the decomposition
into the two classes could, as we have seen, been planned with the intention
of most convincingly asserting the opposite of the conclusion from the ag-
gregate data. If this had been done according to the prescription of (5.7),
then with the same input data, we would have found α = .935, β = .738
(not far from the α = .9, β = .6 corresponding to the additional data pre-
sented) and concluded with the superiority of Hospital B at a confidence
level corresponding to C ′ ≤ .107 or 4.79 standard deviations for each class
of patients.
6 Concluding Remarks
The Simpson paradox, one of the simplest examples of the common misuse
of statistics (think meta-analysis?) has received increasing attention, since
the consequences of its use – or misuse – can be quite severe (as well as
profitable). In the classical Simpson Paradox, the only question is whether
or not to combine data from different sources (and trying to justify the de-
cision to combine). What we have seen here is that the inverse Simpson
paradox, even in its most “sophisticated” version in which mean differences
are weighted by appropriate standard deviations, is nearly universally ap-
plicable. This can be an effective analytical tool, but can equally well be an
effective technique for distorting statistical data.
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A Evaluation of (4.9)
Choosing Bayes with a uniform prior on pA, pB space, (4.9) becomes∫∫
1≥pA≥pB≥0
Pr (SA, SB |pA, pB , NA, NB) dpA dpB /
∫∫
1≥pA,pB≥0
Pr (SA, SB |pA, pB, NA, NB) dpA dpB
=
∫∫
1≥pA≥pB≥0
pSAA p
SB
B q
FA
A q
FB
B dpA dpB /
∫∫
1≥pA,pB≥0
pSAA p
SB
B q
FA
A q
FB
B dpA dpB
=
∫ 1
0
(∫ pA
0
pSBB q
FB
B dpB
)
pSAA q
FA
A dpA /∫ 1
0
∫
pSBB q
FB
B p
SA
A q
FA
A dpB dpA
=
∫ 1
0
BpA (SA + 1, FB + 1) p
SA
A q
FA
A dpA/
B (SB + 1, FB + 1)B (SA + 1, FA + 1) .
(A.1)
Applying the known expansion of the incomplete Beta function [2], this
reduces after a little algebra to
Pr(pA ≥ pB|SA, SB , NA, NB)
=
FA+FB∑
j=0
(
SA+SB+1+j
SA
)(
FA+FB−j
FA
)
/
(
NA+NB+2
NA+1
)
,
(A.2)
or introducing S = SA + SB, N = NA +NB for notational convenience,
Pr(pA ≥ pB |SA, SB, NA, NB)
=
F∑
j=0
(
S+1+j
SA
)(
F−j
FA
)
/
(
N+2
NA+1
) (A.3)
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But we will go to the large sample limit defined by fixed
s = N
−1/2
A
(
SA − 1
2
NA
)
, γ = NA/N,
s′ = N−1/2B
(
SB − 1
2
NB
)
1− γ ≡ NB/N
(A.4)
as N →∞. We could proceed precisely as in (4.5 – 4.8), but if we imagine
a large sample limit from the outset, the derivation is brief and standard.
Consider drug A. A uniform prior for pA is given by the beta distribution
f(pA) = b(1, 1; pA)
where b(m,n; pA) = p
m−1
A q
n−1
A /B(m,n)
B(m1n) = m− 1!n − 1!/m+ n− 1!
(A.5)
which, afterSA successes in NA trials creates the posterior distribution
b(1 + SA, 1 +NA − SA; pA). (A.6)
Drug B works the same way. It follows that
E(pA − pB) = SA + 1
NA + 1
− SB + 1
NB + 1
Var(pA − pB) = (SA + 1)(NA + 1− SA)
(NA + 1)2(NA + 2)
+
(SB + 1)(NB + 1− SB)
(NB + 1)2(NB + 2)
,
(A.7)
and so by the central limit theorem for large NA, NB ,
Pr(pA ≥ pB) = φ
(
SA
NA
− SB
NB
/
(
SA(NA − SA)
N3A
+
SB(NB − SB)
N3B
)1/2)
whereφ(x) =
1√
2π
∫ x
−∞
e−
1
2
y2dy.
(A.8)
B Restrictions on C ′
Eq. (5.3) itself imposes two conditions. Aside from the crucial 0 ≤ PA1, PA2,
PB1, PB2 ≤ 1, there are just two more due to the composition conditions
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that SA1+SA2 = SA, NA1+NA2 = NA, SB1+SB2 = SB , NB1+NB2 = NB .
We reintroduce the notation of Section 2:
NA1 = αNA, NB1 = βNB (B.1)
and hereafter uniformly adopt the notation that
if 0 ≤ x ≤ 1, then x¯ ≡ 1− x. (B.2)
Thus SA1 + SA2 = SA implies PA1NA1 + PA2NA2 = PANA, or
αPA1 + α¯PA2 = PA (B.3)
and similarly
βPB1 + β¯PB2 = PB . (B.4)
We also append (5.3) in the form
PB1 − PA1 = C ′σ1
PB2 − PA2 = C ′σ2,
(B.5)
and solve (B.3), (B.4), (B.5) to yield
PA1 = K1 +
α¯
α− β C
′σB , PA2 = K2 − α
α− β C
′σB,
PB1 = K1 +
β¯
α− β C
′σα, PB2 = K2 − β
α− β C
′σα
(B.6)
where
K1 = (β¯PA − α¯PB)/(α − β), σα = ασ1 + α¯σ2,
K2 = (αPB − βPA)/(α − β), σβ = βσ1 + β¯σ2.
(B.7)
Eqs. (B.6), (B.7) are realizable if the requirements 0 ≤ PA1, PA2, PB1, PB2 ≤
1 are satisfied. Since we are asserting, without loss of generality, that
pA ≥ pB , we of course have the condition
PA ≥ PB , P¯B ≥ P¯A. (B.8)
There are then two cases to consider. If α ≥ β, it is easily seen that K1 ≥ 0,
K2 ≤ 1, so that PA1, PB1 ≥ 0, PA2, PB2 ≤ 1 are already satisfied. The
remaining four conditions PA1, PB1 ≤ 1, PA2, PB2 ≥ 0 can then be gathered
together as
ifα ≥ β then
C ′ ≤ min
(
(α− β)(1 −K1)
α¯σβ
,
(α− β)(1 −K1)
β¯σα
,
(α− β)K2
ασβ
,
(α− β)K2
βσα
)
,
(B.9)
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or, inserting (B.7),
C ′ = min
(
β¯P¯A − α¯P¯B
α¯σβ
,
β¯P¯A − α¯P¯B
β¯σα
,
αPB − βPA
ασβ
,
αPB − βPA
βσα
)
.
(B.10)
Similarly,
ifα ≤ β then
C ′ ≤ min
(
α¯PB − β¯PA
α¯σβ
,
α¯PB − β¯PA
β¯σα
,
βP¯A − αP¯B
ασβ
,
βP¯A − αP¯B
βσα
) (B.11)
Since we require C ′ ≥ 0, immediate consequences are that
if α ≥ β, then α
β
≥ PA
PB
≥ 1, β¯
α¯
≥ P¯B
P¯A
≥ 1
if α ≤ β, α¯
β¯
≥ PA
PB
≥ 1, β
α
≥ P¯B
P¯A
≥ 1
(B.12)
must hold.
C Simplification of (5.4)
The major step is the observation, from (5.2) that
σ2i ≤
N
4
(
1
NAi
+
1
NBi
)
, (C.1)
so that
σ21 ≤
N
4
(
1
αNA
+
1
βNB
)
σ22 ≤
N
4
(
1
α¯NA
+
1
β¯NB
) (C.2)
Hence,
ifα ≥ β, σ21 ≤
1
4β
(
N
NA
+
N
NB
)
σ22 ≤
1
4α¯
(
N
NA
+
N
NB
)
,
(C.3)
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yielding
σ2
σB
} ≤ max(σ1, σ2) ≤ 1
2
(
N
NA
+
N
NB
)1/2
max
(
1
β1/2
,
1
α¯1/2
)
.
(C.4)
Setting NA/N = γ, condition (5.4) can therefore be strengthened to
α ≥ β : C ′ ≤ 2(γγ¯)1/2min(β, α¯)1/2
min
[
1
β¯
(β¯P¯A)− α¯P¯B), 1
α
(αPB − βPA)
]
.
(C.5)
And in the same way, we obtain the strengthened
α ≤ B : C ′ ≤ 2(γγ¯)1/2min(α, β¯)1/2
min
[
1
α¯
(α¯PB − β¯PA), 1
β
(βP¯A − αP¯B)
]
.
(C.6)
Eqs. (C.5) and (C.6) are valid for all α, β, and we may indeed find the
largest feasible range for C ′ by maximizing their right hand sides over α and
β. Again, to reduce complexity, let us take the special case in which:
α ≥ β : α¯/β¯ = (P¯A/P¯B)2, β/α = (PB/PA)2 (C.7)
so that
α = [(PA/PB)
2(P¯B/P¯A)
2 − (PA/PB)2]/
[(PA/PB)
2(P¯B/P¯A)
2 − 1]
β = [(P¯B/P¯A)
2 − 1]/[(PA/PB)2(P¯B/P¯A)2 − 1]
(C.8)
converting (C.5) and (C.6) to
α ≥ β : C ′ ≤ 2(γγ¯)1/2/[(PA/PB)2(P¯B/P¯A)2 − 1]
min[(P¯B/P¯A)
2 − 1, (PA/PB)2 − 1]
·min(P¯A − P¯A2/P¯B , PB − P 2B/PA).
(C.9)
But (P¯A − P¯A2/P¯B) − (PB − P 2B/PA) = (1 − PA − PB)(PA + PB)2/PAP¯B
and ((P¯B/P¯A)
2 − 1)− ((PA/PB)2 − 1) = (PA + PB − 1)PA−PBPAP¯B
(
PA
PB
+ P¯B
P¯A
)
,
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so it follows that in the α ≥ β case,
PA + PB ≥ 1 : C ′ ≤ 2(γγ¯)1/2
((
P¯B
P¯A
)2
− 1
)
(PA − PB)PB
PA
/
[(
PA
PB
P¯B
P¯A
)2
− 1
]
PA + PB ≤ 1 : C ′ ≤ 2(γγ¯)1/2
((
PA
PB
)2
− 1
)
(PA − PB) P¯A
P¯B
/
[(
PA
PB
P¯B
P¯A
)2
− 1
]
(C.10)
are sufficient to carry out the apparent reversal of ranking of A and B. The
decomposition corresponding to the choice α ≤ β can of course be similarly
specialized.
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